Myriad Test May Find Tumor Success After Sanofi Failed

Published January 29, 2011

Myriad Test May Find Tumor Success After Sanofi Failed
Myriad Genetics Inc. Chief Executive Officer Pete Meldrum says his lab test to pinpoint tumors with a specific genetic mutation could have helped Sanofi-Aventis SA succeed if it had been used in a study of a drug that failed in breast cancer.
Read more on BusinessWeek

UK health agency warns over antibiotic resistance
British health authorities issued new guidelines on Saturday to try to halt the spread of “superbug” infections that are resistant to even the most powerful antibiotics, known as carbapenems.
Read more on Reuters via Yahoo! News

Fresh data, few answers in drug overdose report
DAYTON — The number of deaths from unintentional drug poisonings have soared over the past decade in Ohio, from 327 in 1999 to at least 1,373 in 2009.In 2007, unintentional drug overdose became the state’s leading cause of injury death, surpassing motor vehicle crashes and suicide for the first time. The increase in deaths has been driven primarily by prescription drug overdoses.
Read more on Dayton Daily News